Knockdown of the DJ-1 (PARK7) gene sensitizes pancreatic cancer to erlotinib inhibition

This publication has 18 references indexed in Scilit:

• SAHA, an HDAC inhibitor, overcomes erlotinib resistance in human pancreatic cancer cells by modulating E-cadherin
  Tumor Biology, 2015
• Epidermal Growth Factor-dependent Activation of the Extracellular Signal-regulated Kinase Pathway by DJ-1 Protein through Its Direct Binding to c-Raf Protein
  Journal of Biological Chemistry, 2015
• Cotargeting of Epidermal Growth Factor Receptor and PI3K Overcomes PI3K–Akt Oncogenic Dependence in Pancreatic Ductal Adenocarcinoma
  Clinical Cancer Research, 2014
• Identification of RASAL1 as a Major Tumor Suppressor Gene in Thyroid Cancer
  JNCI: Journal of the National Cancer Institute, 2013
• DJ-1 promotes invasion and metastasis of pancreatic cancer cells by activating SRC/ERK/uPA
  Carcinogenesis, 2012
• A Systematic Analysis on DNA Methylation and the Expression of Both mRNA and microRNA in Bladder Cancer
  PLOS ONE, 2011
• Synergistic Effect between Erlotinib and MEK Inhibitors in KRAS Wild-Type Human Pancreatic Cancer Cells
  Clinical Cancer Research, 2011
• Reduced expression of RAS protein activator like‐1 in gastric cancer
  International Journal of Cancer, 2011
• Decreased Expression of the RAS-GTPase Activating Protein RASAL1 Is Associated With Colorectal Tumor Progression
  Gastroenterology, 2009
• DJ-1, a Novel Oncogene Which Transforms Mouse NIH3T3 Cells in Cooperation withras
  Biochemical and Biophysical Research Communications, 1997